8.Matsuoka M, Igisu H. Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia. Biochem Pharmacol. 1993 Jul 6;46(1):159-64. http://www.ncbi.nlm.nih.gov/pubmed/8347126
9.Fariello RG, Zeeman E, Golden GT, Reyes PT, Ramacci T. Transient seizure activity induced by acetylcarnitine. Neuropharmacology. 1984 May;23(5):585-7. http://www.ncbi.nlm.nih.gov/pubmed/6738826
10.Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm. 2012 Jan 1;69(1):35-9. http://www.ncbi.nlm.nih.gov/pubmed/22180549
11.Hiraoka A, Arato T, Tominaga I. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs. Biol Pharm Bull. 1997 Jan;20(1):91-3. http://www.ncbi.nlm.nih.gov/pubmed/9013816